STEPHANIE AGUIRRE: Open Payments
NPI 1285900969 · BABYLON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,554 in 212 payments from 19 companies in 2025. Trend: 2023 $4,320 · 2024 $2,822 · 2025 $3,554
Food & beverage: $3,554
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 13 | $625 |
| VERTEX PHARMACEUTICALS INCORPORATED | 16 | $422 |
| Collegium Pharmaceutical, Inc. | 108 | $404 |
| Averitas Pharma Inc. | 9 | $392 |
| ABBVIE INC. | 13 | $266 |
| Forte Bio-Pharma LLC | 6 | $241 |
| PFIZER INC. | 10 | $215 |
| MML US, Inc. | 4 | $209 |
| BIOTRONIK NRO, Inc. | 5 | $199 |
| Axsome Therapeutics, Inc. | 4 | $99 |
Products named: JOURNAVX, QUTENZA, General - Pain Management, Intracept, XTAMPZA, PROLATE, NURTEC ODT, ReActiv8.
Industry payments across NY — which companies pay providers there.
